Moberg Pharma ABFRA:MB8 -1.12%59 Days Inventory is 254.91 as of Mar. 2026, which is 168% above its 10-year median of 94.97. GuruFocus rates FRA:MB8 with a GF Score™ of 59/100 and a GF Value™ of €1.07. The stock has 1 warning sign investors should review. Among 917 Drug Manufacturers companies, Moberg Pharma AB ranks worse than 87.02% on this metric.
The historical rank and industry rank for Moberg Pharma AB's Days Inventory or its related term are showing as below:
FRA:MB8'
s Days Inventory Range Over the Past 10 Years
Min: 74.78 Med: 94.97 Max: 595.63
Current: 327.16
During the past 13 years, Moberg Pharma AB's highest Days Inventory was 595.63. The lowest was 74.78. And the median was 94.97.
FRA:MB8's Days Inventory is ranked worse than 87.02% of 917
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs FRA:MB8: 327.16
Moberg Pharma AB's Days Inventory
declined
from Mar. 2025 (350.43) to Mar. 2026 (254.91).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Moberg Pharma AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.36.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Moberg Pharma AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.95.
Moberg Pharma AB (FRA:MB8) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Moberg Pharma AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Moberg Pharma AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Moberg Pharma AB Days Inventory Related Terms
Moberg Pharma AB Days Inventory Historical Data
* Premium members only.
The historical data trend for Moberg Pharma AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moberg Pharma AB Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Moberg Pharma AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Moberg Pharma AB (FRA:MB8) has a Days Inventory of 254.91 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Moberg Pharma AB and its competitors. This is 168% above median its historical median of 94.97. Over the past decade, Moberg Pharma AB's Days Inventory has ranged from 74.78 to 595.63. According to the industry distribution chart, Moberg Pharma AB ranks #798 out of 917 companies in the Drug Manufacturers industry, placing it in the top 87%.
Is Moberg Pharma AB's Days Inventory too high?
Moberg Pharma AB's current Days Inventory of 254.91 is 168% above median its 10-year median of 94.97. Over the past 10 years, this metric has ranged from a low of 74.78 to a high of 595.63. The Drug Manufacturers industry median Days Inventory is 164.48. Moberg Pharma AB's value of 254.91 is 55% above this industry median. Based on the distribution chart, Moberg Pharma AB ranks #798 out of 917 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Moberg Pharma AB has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Moberg Pharma AB's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Moberg Pharma AB ranks #798 out of 917 companies for Days Inventory. This places Moberg Pharma AB in the lower half of its industry. The industry median Days Inventory is 164.48. Moberg Pharma AB's value of 254.91 is 55% above this benchmark. Historically, Moberg Pharma AB's own Days Inventory has ranged from 74.78 to 595.63 over the past decade. While the company's 10-year median is 94.97 vs. the industry median of 164.48, Moberg Pharma AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 917 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Moberg Pharma AB's current Days Inventory of 254.91 is 55% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Moberg Pharma AB and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Moberg Pharma AB's current Days Inventory is 254.91, which is 168% above median its own 10-year median of 94.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moberg Pharma AB stock overvalued right now?
Moberg Pharma AB (FRA:MB8) has a current Days Inventory of 254.91. The stock's GF Value™ is €1.07, compared to a current price of €0.80 — trading 25.7% below its estimated fair value. The current Days Inventory is 254.91, which is 168% above median its 10-year median of 94.97 and 55% above the Drug Manufacturers industry median of 164.48. Moberg Pharma AB's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Moberg Pharma AB (FRA:MB8), the current Days Inventory is 254.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Moberg Pharma AB (FRA:MB8) Overvalued in 2026?
Based on GuruFocus' analysis, Moberg Pharma AB stock appears to be undervalued.
The current stock price of €0.80 is trading 25.7% below its estimated GF Value™ of €1.07.
Key valuation signals for FRA:MB8:
Days Inventory: 254.91 (168% above median its 10-year median of 94.97)
GF Value™: €1.07 vs. price of €0.80 (25.7% below fair value)
Industry Position: 55% above the Drug Manufacturers median (#798 of 917)
No single metric tells the full story. See the FRA:MB8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Moberg Pharma AB is a Swedish pharmaceutical company which develops and commercializes proprietary pharmaceuticals based on proven substances. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.
59GF Score
Get the complete analysis for FRA:MB8
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MB8 has been successfully added to your 
